SUS in Sergipe: 235 patients receive free pharmaceutical consultation for treatment with cannabidiol
New service at Case will serve People with aggressive behavior in ASD, using cannabidiol for the first time and registered in Nate
Ana Alice, a homemaker and mother of Daniel, accompanied by the Nucleus of Specialized Therapies Support (Nate), highlighted the importance of public treatment for her son. She shared her experience with the new pharmaceutical consultation service when picking up cannabidiol at the Sergipe Health Care Center (Case).
“Sergipe is a pioneer in providing cannabidiol through the Unified Health System (SUS). Today, I came to get the medication, went through the service, and received clear and concise guidance on correct usage and dosage, with a step-by-step explanation for my son's treatment,” reported in a note from the Government of Sergipe.
Currently, Nate serves 235 patients undergoing treatment with cannabidiol — 173 for controlling aggressive behavior associated with ASD and 62 for refractory epilepsy. The data, obtained by the Sechat Portal report, refers to August 2025.
Pioneering service in the State
On Thursday, August 13, the Government of Sergipe announced the inauguration of the pharmaceutical consultation service at Case, a facility linked to the State Department of Health (SES). The service includes an evaluation of the medications used by patients and guidance to ensure appropriate treatment, focusing on optimizing pharmacotherapy.
In a statement, the coordinator of Pharmaceutical Assistance at SES, Juliana Santos, explained that the service will initially serve patients with Autism Spectrum Disorder (ASD), type 2 diabetes, and multiple sclerosis.
“Pharmaceutical consultations bring advancement to pharmaceutical care in Sergipe, delivering more comprehensive care to users' needs. Additionally, they ensure greater proximity between healthcare professionals and patients, with personalized monitoring,” she stated.
State cannabis policy
In April 2023, Sergipe instituted Law No. 9,178, establishing the State Cannabis Policy. Nate provides comprehensive health support, with medical, nutritional, and multiprofessional care.
The new service at Case will serve patients who meet specific criteria, including individuals with aggressive behavior in ASD, using cannabidiol for the first time, and registered in Nate.
It will also serve patients with multiple sclerosis using cladribine and patients with type 2 diabetes, over 60 years old, using insulin and dapagliflozin.
“Pharmacists will effectively integrate patient care, reinforcing Nate's multiprofessional approach. In addition to medical and nutritional support, patients will have clinical support from the pharmacist, who monitors correct medication use, prevents interactions and adverse reactions, and provides individualized guidance for greater effectiveness and safety,” highlighted Juliana Santos.
To access the service, the patient must go to Case for scheduling, provided they meet the established criteria.
With information from Gov. Sergipe